Proton Therapy Pediatric denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for proton therapy pediatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Pediatric Proton Therapy on Medical-Necessity Grounds

A medical-necessity denial for pediatric proton therapy typically means Aetna's reviewer concluded that the clinical record submitted at the time of prior authorization did not sufficiently demonstrate that proton therapy — rather than conventional radiation — is required for this patient's specific diagnosis, anatomy, and clinical circumstances. These denials often hinge on whether the documentation addresses the plan's medical-necessity criteria rather than on whether the treatment is appropriate in an absolute sense.

## Why This Denial Is Appealable

Medical necessity is defined by the plan's own policy, and that definition can be met with the right documentation. Pediatric oncology cases frequently have strong clinical grounds: tumor proximity to critical structures, the child's age and developmental stage, and long-term survivorship considerations are all medically relevant factors that distinguish a child's needs from a generic adult benchmark. A well-documented appeal that directly maps the plan's criteria to the child's chart facts overturns these denials at a meaningful rate.

## Federal Appeal Framework

• Internal appeal: Must be submitted within 180 days of the denial notice. Aetna is required to provide a written decision with the clinical rationale.
• External review (ACA §2719): After an adverse internal decision, request external review by an accredited IRO. The IRO's determination is binding.
• ERISA §503: Employer-sponsored plan members have the right to a full-and-fair review including access to the criteria applied and any clinical guidelines relied upon.
• Expedited review: Request immediately in writing if the standard timeline would jeopardize the patient's health — particularly important when treatment delays affect tumor control.
• External review window: Typically four months from the final internal denial.

## Documentation to Gather

• Complete diagnosis documentation: Pathology report, MRI/CT/PET imaging with radiology reads, staging, and multidisciplinary tumor board recommendation.
• Clinical-necessity letter from the radiation oncologist: Should explain in specific, individualized terms why proton therapy is necessary for this child — not a form letter, but a narrative tied to this patient's anatomy, tumor location, and organs at risk.
• Dosimetric plan comparison: Quantitative comparison of proton versus photon dose distributions for this patient's specific treatment plan, prepared by the treating institution.
• Pediatric oncologist's supporting documentation: Chart notes and correspondence confirming the coordinated treatment recommendation.
• Prior treatment history: All prior oncologic treatments, dates, responses, and any prior radiation fields.

## Criteria-Mapping Structure

Obtain a copy of Aetna's medical-necessity criteria for proton beam therapy in pediatric patients from the denial letter or by request. Format your appeal as a numbered response: quote each criterion exactly as written in the policy, then immediately follow it with the specific chart fact, document name, date, and author that satisfies it. Reviewers and IRO panelists respond to organized, criterion-by-criterion responses. Avoid general arguments about proton therapy's merit — focus entirely on demonstrating that this patient meets the plan's own stated criteria.